Kajaria Ceramics Merger & Restructuring Worth ₹12.15 Cr

Kajaria Ceramics Earnings Call Transcript: Key Takeaways

Kajaria delivered solid volume growth and margin expansion despite subdued exports from Morbi. Management remains optimistic about double-digit volume growth driven by domestic demand and capacity expansions.

Call

Guides 10% growth

Kajaria Ceramics Capacity Expansion: ₹34 Cr Investment

Kajaria Ceramics will build a Rs.34 Crore tile adhesive plant in Durgapur, adding 9,000 MT monthly capacity. Completion is targeted by December 2027.

Value

₹34.00 Cr

Execution

Expected to be set up by December 2027

tile adhesive manufacturing capacity

9000.0 MT per month

Kajaria Ceramics Capacity Expansion: ₹340 Cr Investment

Kajaria Ceramics' board approved a 12.50 MSM per annum glazed vitrified tile capacity addition at ₹340 Crore. Completion is expected by June 2027, financed through internal accruals and debt.

Value

₹340.0 Cr

Execution

Expected to be completed by June 2027

glazed vitrified tile manufacturing capacity

12.5 MSM per annum

Kajaria Ceramics Capacity Expansion: ₹180 Cr Investment

Kajaria Ceramics' board approved an 11 MSM per annum tile capacity addition at an investment of ₹180 Crore. Completion is expected by April 2027, financed through internal accruals and debt.

Value

₹180.0 Cr

Execution

Expected to be completed by April 2027

tile manufacturing capacity

11.0 MSM per annum

Kajaria Ceramics Capacity Expansion

Kajaria Ceramics will add 11 MSM of tile capacity per annum, expected by April 2027. The investment is Rs 180 Crore, funded by internal accruals and debt.

Execution

Expected completion by April 2027

tile manufacturing capacity

11.0 MSM per annum

Kajaria Ceramics Dividend

Kajaria Ceramics declared an interim dividend of Rs 12 per equity share for 2026-27. The record date is 29 October 2026, with payment by 22 November 2026.

Quint Digital Merger & Restructuring

Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.

Hexaware Technologies Merger & Restructuring

Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.

Execution

Expected completion by 30 June 2027; agreement date stated as 1 December 2026

Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr

Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.

Value

₹2.75 Cr

Execution

Completion expected by 26 January 2027

TVS Holdings Merger & Restructuring

TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.

Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr

Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.

Value

₹30.00 Cr

Execution

Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals

Fortis Healthcare Merger & Restructuring Worth ₹277 Cr

Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.

Value

₹277.0 Cr